Article
Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C. Blood Cells Mol Dis, 2014. [Citation]
Annotations by Allele
- DOL - partly characterized or subtypes not separated: Prevalence
- DOL - partly characterized or subtypes not separated: Prevalence
- RHD deletion (RHD*01N.01): Prevalence
- RHD deletion (RHD*01N.01): Prevalence
- RHD*1136T (DAU0): Prevalence
- RHD*1136T (DAU0): Prevalence
- RHD*165T (DBO1): Prevalence
- RHD*165T (DBO1): Prevalence
- RHD*186T,364A,873A: Prevalence
- RHD*186T,410T,455C (DIII type 4): Prevalence
- RHD*186T,410T,455C (DIII type 4): Prevalence
- RHD*186T,410T,455C,1048C (DIVa): Prevalence
- RHD*186T,410T,455C,1048C (DIVa): Prevalence
- RHD*186T,410T,455C,602G,667G,819A (DIIIa): Prevalence
- RHD*186T,410T,455C,602G,667G,819A (DIIIa): Prevalence
- RHD*361A,380C,383G,455C (DIIIc): Prevalence
- RHD*384C: Prevalence
- RHD*509C,667G,1132G (DOL2, RHD*12.02): Prevalence
- RHD*509C,667G,1132G (DOL2, RHD*12.02): Prevalence
- RHD*541T: Prevalence
- RHD*579A,1136T (DAU0.01): Prevalence
- RHD*579A,1136T (DAU0.01): Prevalence
- RHD*602G (weak D type 40): Prevalence
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): Prevalence
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): Prevalence
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Prevalence
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Prevalence
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): Prevalence
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): Prevalence
- RHD*667G (DFV, RHD*08.01): Prevalence
- RHD*667G (DFV, RHD*08.01): Prevalence
- RHD*667G,1136T (DAU): Prevalence
- RHD*667G,697C,1136T (DAU5): Prevalence
- RHD*667G,697C,1136T (DAU5): Prevalence
- RHD*697A,1136T (DAU4): Prevalence
- RHD*697A,1136T (DAU4): Prevalence
- RHD*835A,1136T (DAU3): Prevalence
- RHD*835A,1136T (DAU3): Prevalence
- RHD*841C: Prevalence
- RHD*941T (RHD*01N.20): Prevalence
- RHD*963A: Prevalence
- RHD*998A,1136T (DAU6): Prevalence
- RHD*998A,1136T (DAU6): Prevalence
- RHD*D-CE(2-7)-D (RHD*01N.05): Prevalence
- RHD*D-CE(2-7)-D (RHD*01N.05): Prevalence
- RHD*D-CE(4-7)-D (RHD*01N.07): Prevalence
- RHD*D-CE(4-7)-D (RHD*01N.07): Prevalence
- RHD*D-ceEK(2-7)-D: Prevalence
- RHD*D-CEVS(4-7)-D (RHD*01N.06): Prevalence
- RHD*DIIIa(384C): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
- RHD*Dpsi (RHD*08N.01): Prevalence
- RHD*Dpsi (RHD*08N.01): Prevalence
- standard RHD (RHD*01): Prevalence
- standard RHD (RHD*01): Prevalence